Enimmune Corporation (TPEX:6564)

Enimmune Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	167.55	202.39	484.91	359.89	394.17	118.39
Short-Term Investments	4.9	23.4	4.9	4.9	92.9	231.4
Cash & Short-Term Investments	172.45	225.79	489.81	364.79	487.07	349.79
Cash Growth	-35.53%	-53.90%	34.27%	-25.11%	39.25%	-17.46%
Accounts Receivable	14.64	14.52	12.5	11.92	5.22	21.99
Other Receivables	31.88	31.44	29.73	28.38	28.55	25.54
Receivables	46.52	45.96	42.23	40.3	33.77	47.53
Inventory	22.63	21.23	35.64	37.64	88.12	82.82
Prepaid Expenses	3.02	2.63	2.58	4.9	2.37	2.05
Other Current Assets	22.37	22.57	17.79	17.59	16.54	1.37
Total Current Assets	266.98	318.18	588.04	465.21	627.87	483.55
Property, Plant & Equipment	11.59	14.14	3.86	5.88	8.52	5.92
Other Intangible Assets	96.59	99.08	104.17	109.27	114.38	119.48
Other Long-Term Assets	24.48	24.71	27.63	24.47	24.33	1.12
Total Assets	399.64	456.1	723.7	604.83	775.09	610.07

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	26.51	2.85	2.95	18.06	4	10.36
Accrued Expenses	11.28	29.87	19.4	32.39	-	-
Short-Term Debt	100.05	125	100	40	20	-
Current Portion of Long-Term Debt	20	10	2.24	2.13	2.11	2.09
Current Portion of Leases	3.51	3.48	0.78	1.84	1.82	0.78
Current Unearned Revenue	-	-	-	-	-	1.72
Other Current Liabilities	101.89	102.49	114.35	77.28	76.02	19.88
Total Current Liabilities	263.24	273.7	239.71	171.7	103.95	34.82
Long-Term Debt	33.22	28.22	4.78	0.98	3.11	5.22
Long-Term Leases	2.79	4.49	-	0.78	2.62	-
Total Liabilities	299.25	306.41	244.49	173.46	109.68	40.04

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	721.34	721.34	721.34	658	658	600
Additional Paid-In Capital	26.98	25.67	160.64	11.56	168.02	17.27
Retained Earnings	-638.78	-588.81	-509.82	-344.93	-281.33	-47.25
Comprehensive Income & Other	-9.15	-8.51	1.91	-2.68	-0.15	-
Total Common Equity	100.39	149.69	374.06	321.95	544.54	570.03
Minority Interest	-	-	105.14	109.41	120.87	-
Shareholders' Equity	100.39	149.69	479.2	431.36	665.41	570.03
Total Liabilities & Equity	399.64	456.1	723.7	604.83	775.09	610.07

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	159.57	171.19	107.8	45.73	29.66	8.08
Net Cash (Debt)	12.88	54.59	382	319.06	457.41	341.7
Net Cash Growth	-87.14%	-85.71%	19.73%	-30.25%	33.86%	-17.02%
Net Cash Per Share	0.18	0.76	5.34	4.85	7.16	5.70
Filing Date Shares Outstanding	72.13	72.13	72.13	65.8	65.8	60
Total Common Shares Outstanding	72.13	72.13	72.13	65.8	65.8	60
Working Capital	3.74	44.47	348.33	293.51	523.92	448.73
Book Value Per Share	1.39	2.08	5.19	4.89	8.28	9.50
Tangible Book Value	3.8	50.61	269.9	212.68	430.16	450.55
Tangible Book Value Per Share	0.05	0.70	3.74	3.23	6.54	7.51
Machinery	6.5	6.5	5.39	4.92	4.92	4.65
Leasehold Improvements	5.67	5.67	2.6	2.6	2.6	2.52

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error